Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
PBH 
Prestige Brand Holdings Inc (PBH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: PBH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $82.8
1 Year Target Price $82.8
| 3 | Strong Buy |
| 0 | Buy |
| 3 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -11.39% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/16/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.11B USD | Price to earnings Ratio 14.84 | 1Y Target Price 82.8 |
Price to earnings Ratio 14.84 | 1Y Target Price 82.8 | ||
Volume (30-day avg) 7 | Beta 0.46 | 52 Weeks Range 61.93 - 90.04 | Updated Date 09/16/2025 |
52 Weeks Range 61.93 - 90.04 | Updated Date 09/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 4.26 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 19.02% | Operating Margin (TTM) 28.76% |
Management Effectiveness
Return on Assets (TTM) 6.47% | Return on Equity (TTM) 12.05% |
Valuation
Trailing PE 14.84 | Forward PE 13.87 | Enterprise Value 4002238347 | Price to Sales(TTM) 2.78 |
Enterprise Value 4002238347 | Price to Sales(TTM) 2.78 | ||
Enterprise Value to Revenue 3.57 | Enterprise Value to EBITDA 11.06 | Shares Outstanding 49214200 | Shares Floating 48647224 |
Shares Outstanding 49214200 | Shares Floating 48647224 | ||
Percent Insiders 1.26 | Percent Institutions 107.87 |
Upturn AI SWOT
Prestige Brand Holdings Inc
Company Overview
History and Background
Prestige Brands Holdings, Inc. was founded in 1996. It has grown through numerous acquisitions of over-the-counter healthcare and household cleaning brands.
Core Business Areas
- Healthcare: Over-the-counter (OTC) healthcare products, including cough & cold, analgesics, and skincare.
- Household Cleaning: Household cleaning products.
Leadership and Structure
The leadership team consists of the CEO, CFO, and other key executives. The company operates with a functional organizational structure.
Top Products and Market Share
Key Offerings
- Clear Eyes: Eye care products, competing with Visine (JNJ) and Refresh (Allergan). Market share information requires specific market data resources and is not available here.
- BC Powder: Pain relief powder. Competitors include Goody's Powder, Excedrin (GSK).
- Chloraseptic: Sore throat relief products. Competitors include Cepacol (Reckitt Benckiser).
- Compeed: Blister care. Competitors include Band-Aid brand products from Kenvue (KVUE).
Market Dynamics
Industry Overview
The OTC healthcare market is characterized by stable demand, driven by an aging population and increasing consumer self-care trends. The household cleaning market is affected by changes in consumer preferences and regulatory environments.
Positioning
Prestige Brands occupies a niche within the OTC healthcare and household cleaning markets, focusing on acquiring and growing established brands. Its competitive advantage lies in its brand management and distribution capabilities.
Total Addressable Market (TAM)
The global OTC market is valued in the hundreds of billions of dollars. Prestige Brands holds a small portion of the market, focusing on growing its core brands within specific segments.
Upturn SWOT Analysis
Strengths
- Established brand portfolio
- Strong distribution network
- Proven acquisition strategy
- Experienced management team
Weaknesses
- High debt levels (historically)
- Reliance on acquisitions for growth
- Limited organic growth
- Exposure to private label competition
Opportunities
- Further acquisitions of complementary brands
- Expansion into new geographic markets
- Innovation in product development
- Growing demand for self-care products
Threats
- Increased competition from larger players
- Changing consumer preferences
- Regulatory changes
- Economic downturns
Competitors and Market Share
Key Competitors
- JNJ
- GSK
- RBGLY
- KVUE
Competitive Landscape
Prestige Brands competes with larger pharmaceutical and consumer goods companies. Its advantages include its focused brand portfolio and efficient distribution network. Disadvantages include limited scale and higher debt levels.
Major Acquisitions
DenTek Oral Care
- Year: 2017
- Acquisition Price (USD millions): 530
- Strategic Rationale: Expanded Prestige's oral care portfolio.
Growth Trajectory and Initiatives
Historical Growth: Prestige Brands has historically grown through acquisitions, supplemented by organic growth of existing brands.
Future Projections: Future growth projections depend on analyst estimates and company guidance, which is not available here.
Recent Initiatives: Recent initiatives include strategic acquisitions, product innovation, and optimization of the brand portfolio.
Summary
Prestige Brands is a player in the OTC healthcare and household cleaning markets, focusing on acquiring and growing established brands. Its strength lies in its brand portfolio and distribution capabilities, but faces challenges due to debt and large competitors. The company can benefit from strategic acquisitions and organic growth. They also must monitor consumer trends.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- Public filings
- Industry reports
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market share percentages are estimates.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Prestige Brand Holdings Inc
Exchange NYSE | Headquaters Tarrytown, NY, United States | ||
IPO Launch date 2005-02-10 | Chairman, President & CEO Mr. Ronald M. Lombardi CPA | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 600 | Website https://www.prestigebrands.com |
Full time employees 600 | Website https://www.prestigebrands.com | ||
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.